Elaiapharm provides pharmaceutical contract manufacturing services (contract development & manufacturing organisation - CDMO), combining high level of quality, skills and performance, particularly in:
- Pharmaceutical Development
- Manufacture of commercial and clinical batches (in solid, sterile liquid and freeze-dried forms)
- Commercial packaging
- Production of pharmaceutical active ingredients
- Analytical services and development, ICH stability testing
Teams possessing high levels of skills and expertise are put to work on meeting your requirements, both for medicinal products and medical devices, all in compliance with current standards. Our dedicated teams, recognised for their attentive approach, manage your projects flexibly, quickly and within your budget constraints. Our objective is to ensure our customers can complete their projects delivering high levels of quality and services, within their deadlines.
Our range of CDMO services range from ad-hoc individual services to comprehensive turnkey provision, from formulating the active principle, to sale of the end product, via analytical and clinical services.
We invest regularly in our production sites, to remain at the leading edge of manufacturing performance in terms of equipment and facilities, and to provide the capacity necessary to develop our customers’ businesses.
Our sites are regularly, and successfully, inspected by various authorities, including France (ANSM), Brazil (ANVISA), USA (FDA) and Japan (PMDA) to guarantee to our customers that our sites, facilities and procedures comply with current GMP standards.
Lastly, our sites are certified under ISO 14001 and OHSAS 18001, confirming our compliance with safety and environmental requirements.